Effect of polymyxin b-immobilized fiber on serum phosphate concentrations in patients with sepsis [10]

Nephron

Volumn 86, Issue 3, 2000, Pages 359-360

  Shimada, Noriaki ^a   Nakamura, Tsukasa ^b   Takahashi, Yutaka ^c   Tanaka, Araki ^c   Shoji, Hisataka ^d   Sekizuka, Keiko ^a   Ebihara, Isao ^a   Koide, Hikaru ^a  

^a KOTO HOSPITAL   (Japan)

^b Misato Junshin Hospital   (Japan)

^c Mizue Dialysis Center   (Japan)

^d Toray Medical Company   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6 RECEPTOR; NEOPTERIN; PHOSPHATE; POLYMYXIN B;

CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; HEMOPERFUSION; HUMAN; HYPOPHOSPHATEMIA; LETTER; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SEPSIS; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; HUMANS; HYPOPHOSPHATEMIA; MEMBRANES, ARTIFICIAL; PHOSPHATES; POLYMYXIN B; SEPSIS;

EID: 0033673214     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome
2. Molecular aspects of endotoxins relevant to their biological functions
3. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber
4. Extracorporeal endotoxin removal by polymyxin B-immobilized fiber cartridge: Designing and antiendotoxin efficacy in the clinical application
5. Effects of hemoperfusion with polymyxin B-immobilized fibre on serum neopterin and soluble interleukin-2 receptor concentrations in patients with septic shock
6. Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiber
7. Prevalence of hypophosphatemia in sepsis and infection: The role of cytokines
8. Sepsis syndrome: A valid clinical entity